StockData
Aquestive Therapeutics, Inc. logo

Aquestive Therapeutics, Inc. (AQST) stock

AQSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 3/30
$3.78+0.08 (+2.16%)

Close on Nov 18, 2026Market cap $474.43MP/E –Yield –

Aquestive Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Aquestive Therapeutics's price to book ratio was 14.1× on Apr 30, 2019.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2019Apr 30, 201914.1×+7.4
2018Dec 31, 20186.7×–

More Aquestive Therapeutics figures

See a number that looks wrong?